相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination
Tara M. Vogt et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction
A. Dominguez et al.
VACCINE (2008)
Control of hepatitis A by universal vaccination of adolescents, Puglia, Italy
Pietro Luigi Lopalco et al.
EMERGING INFECTIOUS DISEASES (2008)
Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma
Gianvincenzo Zuccotti et al.
VACCINE (2007)
Concomitant administration of a virosome-adjuvanted hepatitis A vaccine with routine childhood vaccines at age twelve to fifteen months: A randomized controlled trial
Ron Dagan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis a vaccine -: A controlled trial in children aged 1-16 years
Marie Van Der Wielen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal®) in the elderly
V D'Acremont et al.
JOURNAL OF TRAVEL MEDICINE (2006)
Incidence of hepatitis A in Israel following universal immunization of toddlers
R Dagan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Incidence of hepatitis A in the United States in the era of vaccination
A Wasley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine
PA Bovier et al.
VACCINE (2005)
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity
L Bungener et al.
VACCINE (2005)
Influenza virosomes as an efficient system for adjuvanted vaccine delivery
R Glück et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Rapid antibody response after vaccination with a virosomal hepatitis A vaccine
F Ambrosch et al.
INFECTION (2004)
Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines
XY Wang et al.
VACCINE (2004)
Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal®)
V Usonis et al.
VACCINE (2003)
Successful booster antibody response up to 54 months after single primary vaccination with virosome-formulated, aluminum-free hepatitis A vaccine
BR Beck et al.
CLINICAL INFECTIOUS DISEASES (2003)
Hepatitis A booster vaccination: is there a need?
P Van Damme et al.
LANCET (2003)
Efficacy of virosome hepatitis A vaccine in young children in nicaragua:: Randomized placebo-controlled trial
OM Pérez et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
New technology platforms in the development of vaccines for the future
R Glück et al.
VACCINE (2002)
Long-term immunogenicity of an inactivated virosome hepatitis A vaccine
PA Bovier et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Virosome-mediated delivery of protein antigens to dendritic cells
L Bungener et al.
VACCINE (2002)
Hepatitis A virus infections in the United States: Model-based estimates and implications for childhood immunization
GL Armstrong et al.
PEDIATRICS (2002)
Control of hepatitis A through routine vaccination of children
F Averhoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Immunization against hepatitis A in the first year of life: Priming despite the presence of maternal antibody
R Dagan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience
C Germinario et al.
VACCINE (2000)
分享论文
